Alteration of immunohistochemic ...
The immunohistochemical (IHC) biomarkers of breast cancer, especially hormone receptors and HER2, are very important because the pharmacological the ...
Suspicious calcifications in be ...
Background Breast cancer screening by mammography (MMG) has recently increased in Japan. Suspicious lesions are therefore being detected more and mo ...
Lymphedema and breast cancer: a ...
Breast cancer continues to be the most common malignancy among women in the United States. Despite its high incidence, early detection and modern tr ...
Neoadjuvant endocrine therapy f ...
Patients with resectable, nonmetastatic (stage I–IIIA) breast cancer usually receive adjuvant (postoperative) systemic therapy to control micrometas ...
A histopathological study for e ...
Purpose To reveal the rate of complete therapeutic effect of radiofrequency ablation (RFA) and its correlation with tumor size by the histopathologi ...
Current strategy for triple-neg ...
Triple-negative breast cancer (TNBC) often grows rapidly and has poor outcomes, with a high recurrence rate and a short interval between recurrence ...
Neoadjuvant endocrine therapy o ...
Aromatase inhibitors (AIs) were more effective than tamoxifen as a neoadjuvant endocrine therapy (NAE) for postmenopausal women with estrogen recept ...
Histopathological effect of rad ...
Radiofrequency ablation (RFA) therapy is expected to be applicable to small breast cancers, but no criteria for its histopathological effect have ye ...
MR imaging of triple-negative b ...
Little is known about the MR imaging features of triple-negative breast cancer (TNBC), but TNBC has a worse prognosis because it has no effective th ...
Preoperative therapy: recent fi ...
Preoperative systemic therapy (PST) is the standard treatment for locally advanced breast cancer and a standard option for primary operable breast c ...
MR and US imaging for breast ca ...
Background Neoadjuvant chemotherapy (NAC) is commonly utilized to treat operable breast cancer. The purpose of this study was to review the findings ...
Radiofrequency ablation as loca ...
Purpose To evaluate the safety and efficacy of radiofrequency ablation (RFA) as a local therapy for early breast carcinomas, we performed a phase I/ ...
Primary systemic chemotherapy o ...
Primary systemic chemotherapy has become a standard of care for operable breast cancer patients who are candidates for adjuvant chemotherapy. Induct ...
Pilot study of radiofrequency a ...
Background There is increasing demand for minimally invasive treatments for small breast cancer mainly because of the desire for better cosmetic res ...
Lifecourse predictors of mammog ...
Dense mammographic patterns are a strong predictor of breast cancer risk. Factors at differing stages of life have been linked to breast cancer risk ...
Effect of the overexpression of ...
Breast Cancer 2 gene (BRCA2) mutation carriers have a 45% chance of developing breast cancer and a 11% risk of developing ovarian cancer by the age ...
CD8+ cytotoxic T cell and FOXP3 ...
The prognostic significance of tumor-associated FOXP3? regulatory T cells (Tregs) and CD8? cytotoxic T lymphocytes (CTLs) in invasive breast carcino ...
Are symptomatic guidelines for ...
Oncologists recommend chemotherapy to postmenopausal women with adverse prognostic factors, but predictors of the benefit of chemotherapy are mainly ...
Distinct expressions of microRN ...
Estrogen receptor (ER) a is essential for estrogen-dependent growth, and its level of expression is a crucial determinant of response to endocrine t ...
RecurrenceOnline: an online ana ...
In the last decades, several gene expressionbased predictors of clinical behavior were developed for breast cancer. A common feature of these is the ...
A non-BRCA1/2 hereditary breast ...
Germline mutations in BRCA1 and BRCA2 explain approximately 25% of all familial breast cancers. Despite intense efforts to find additional high-risk ...
Metaplastic sarcomatoid carcino ...
Metaplastic sarcomatoid carcinoma (MSC) of the breast is usually triple receptor (ER, PR, and HER2) negative and is not currently recognized as bein ...
Glucocorticoid receptor and bre ...
Stress enhances glucocorticoid (GC) synthesis, which alters inflammation and immune responses, as well as cellular proliferation and apoptosis in a ...
ADAM12 induces estrogen-indepen ...
Antiestrogen therapy has been used successfully to prolong disease-free and overall survival of ER positive breast cancer patients. However, 50% of ...
Struggling with subtypes: tryin ...
Modern understanding of breast cancer as a disease has undisputedly left the ‘‘Halstedian’’ worldview and has entered the molecular age. Formerly, b ...